These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25844674)

  • 1. Metastatic carcinoma of unknown primary: diagnostic approach using immunohistochemistry.
    Conner JR; Hornick JL
    Adv Anat Pathol; 2015 May; 22(3):149-67. PubMed ID: 25844674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoma of unknown primary: check the liver... thanks to TTF-1.
    Mishra M; Morgan V; Hamati AK; Al-Abbadi M
    Tenn Med; 2012 Jan; 105(1):35-6, 40. PubMed ID: 22359993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical identification of carcinomas of unknown primary in serous effusions.
    Pomjanski N; Grote HJ; Doganay P; Schmiemann V; Buckstegge B; Böcking A
    Diagn Cytopathol; 2005 Nov; 33(5):309-15. PubMed ID: 16240395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDX2, SATB2, GATA3, TTF1, and PAX8 Immunohistochemistry in Krukenberg Tumors.
    Chiesa-Vottero A
    Int J Gynecol Pathol; 2020 Mar; 39(2):170-177. PubMed ID: 32045390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistologic evaluation of metastatic carcinomas of unknown origin: an algorithmic approach.
    DeYoung BR; Wick MR
    Semin Diagn Pathol; 2000 Aug; 17(3):184-93. PubMed ID: 10968704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SATB2 is a supplementary immunohistochemical marker to CDX2 in the diagnosis of colorectal carcinoma metastasis in an unknown primary.
    Dabir PD; Svanholm H; Christiansen JJ
    APMIS; 2018 Jun; 126(6):494-500. PubMed ID: 29924451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of carcinoma origin by thyroid transcription factor-1 immunostaining of fine needle aspirates of metastases.
    Strojan Flezar M; Srebotnik Kirbis I
    Cytopathology; 2009 Jun; 20(3):176-82. PubMed ID: 18373697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoma of unknown primary (CUP); some considerations about pathogenesis and diagnostic strategy, particularly focusing on CUPS pertaining to the Urology.
    Alberti C
    G Chir; 2012; 33(1-2):41-6. PubMed ID: 22357439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer of Unknown Primary: A Review on Clinical Guidelines in the Development and Targeted Management of Patients with the Unknown Primary Site.
    Qaseem A; Usman N; Jayaraj JS; Janapala RN; Kashif T
    Cureus; 2019 Sep; 11(9):e5552. PubMed ID: 31695975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaplastic large-cell lymphoma with aberrant expression of multiple cytokeratins masquerading as metastatic carcinoma of unknown primary.
    Nguyen TT; Kreisel FH; Frater JL; Bartlett NL
    J Clin Oncol; 2013 Nov; 31(33):e443-5. PubMed ID: 23775969
    [No Abstract]   [Full Text] [Related]  

  • 11. Practical Applications in Immunohistochemistry: Carcinomas of Unknown Primary Site.
    Kandalaft PL; Gown AM
    Arch Pathol Lab Med; 2016 Jun; 140(6):508-23. PubMed ID: 26457625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of SATB2 as a diagnostic marker for tumors of colorectal origin: Results of a pathology-based clinical prospective study.
    Dragomir A; de Wit M; Johansson C; Uhlen M; Pontén F
    Am J Clin Pathol; 2014 May; 141(5):630-8. PubMed ID: 24713733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CUP syndrome: are there advances?].
    Moll R
    Verh Dtsch Ges Pathol; 2005; 89():125-36. PubMed ID: 18035682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours.
    Rabban JT; Zaloudek CJ
    Histopathology; 2013 Jan; 62(1):71-88. PubMed ID: 23240671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm.
    Dennis JL; Hvidsten TR; Wit EC; Komorowski J; Bell AK; Downie I; Mooney J; Verbeke C; Bellamy C; Keith WN; Oien KA
    Clin Cancer Res; 2005 May; 11(10):3766-72. PubMed ID: 15897574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemistry, carcinomas of unknown primary, and incidence rates.
    Stelow EB; Yaziji H
    Semin Diagn Pathol; 2018 Mar; 35(2):143-152. PubMed ID: 29224972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma.
    Su YC; Hsu YC; Chai CY
    Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical diagnosis of hepatocellular carcinoma and identification of carcinomas of unknown primary metastatic to the liver on fine-needle aspiration cytologies.
    Onofre AS; Pomjanski N; Buckstegge B; Böcking A
    Cancer; 2007 Aug; 111(4):259-68. PubMed ID: 17567831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors.
    Chia SY; Thike AA; Cheok PY; Tan PH
    Breast; 2010 Oct; 19(5):355-9. PubMed ID: 20347310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical panel of antibodies in the diagnosis of brain metastases of the unknown primary.
    Drlicek M; Bodenteich A; Urbanits S; Grisold W
    Pathol Res Pract; 2004; 200(10):727-34. PubMed ID: 15648611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.